Australia markets closed

ADMA Biologics, Inc. (ADMA)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
9.06-0.04 (-0.44%)
At close: 04:00PM EDT
9.25 +0.19 (+2.10%)
After hours: 07:59PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 2.10B
Enterprise value 2.20B
Trailing P/E N/A
Forward P/E 24.51
PEG ratio (5-yr expected) N/A
Price/sales (ttm)7.28
Price/book (mrq)13.66
Enterprise value/revenue 7.76
Enterprise value/EBITDA 78.31

Trading information

Stock price history

Beta (5Y monthly) 0.43
52-week change 3120.98%
S&P500 52-week change 326.36%
52-week high 39.33
52-week low 33.06
50-day moving average 36.63
200-day moving average 34.81

Share statistics

Avg vol (3-month) 32.84M
Avg vol (10-day) 33.87M
Shares outstanding 5231.81M
Implied shares outstanding 6231.81M
Float 8227.23M
% held by insiders 12.84%
% held by institutions 177.63%
Shares short (30 Apr 2024) 48.72M
Short ratio (30 Apr 2024) 44.27
Short % of float (30 Apr 2024) 43.88%
Short % of shares outstanding (30 Apr 2024) 43.76%
Shares short (prior month 28 Mar 2024) 47.29M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin -1.29%
Operating margin (ttm)26.65%

Management effectiveness

Return on assets (ttm)8.51%
Return on equity (ttm)-2.43%

Income statement

Revenue (ttm)283.18M
Revenue per share (ttm)1.25
Quarterly revenue growth (yoy)43.90%
Gross profit (ttm)N/A
EBITDA 55.47M
Net income avi to common (ttm)-3.64M
Diluted EPS (ttm)-0.02
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)45.33M
Total cash per share (mrq)0.2
Total debt (mrq)141.43M
Total debt/equity (mrq)92.01%
Current ratio (mrq)5.21
Book value per share (mrq)0.66

Cash flow statement

Operating cash flow (ttm)21.3M
Levered free cash flow (ttm)7.84M